Monday, March 13, 2017 3:33:10 PM
You shall not covet your neighbor’s house. You shall not covet your neighbor’s wife, or his male or female servant, his ox or donkey, or anything that belongs to your neighbor.
—?Exodus 20:17
ILMN
—?Exodus 20:17
ILMN
252023202112011074207
Recent ILMN News
- DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows • PR Newswire (US) • 04/16/2026 01:15:00 PM
- Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease • PR Newswire (US) • 04/14/2026 01:15:00 PM
- Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026 • PR Newswire (US) • 04/09/2026 08:30:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/09/2026 08:21:21 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/09/2026 08:18:50 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/09/2026 08:16:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:32:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:09:56 PM
- Illumina Announces Changes to Board of Directors • PR Newswire (US) • 04/02/2026 01:07:00 PM
- Illumina and Labcorp expand collaboration to broaden access to precision oncology testing • PR Newswire (US) • 03/18/2026 01:15:00 PM
- Illumina advances preventive genomics through strategic consortium with Veritas Genetics • PR Newswire (US) • 03/16/2026 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:06:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:05:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:04:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:01:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 08:59:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 08:56:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 08:55:02 PM
- Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering • PR Newswire (US) • 03/05/2026 02:15:00 PM
- Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida • PR Newswire (US) • 02/27/2026 02:15:00 PM
- Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics • PR Newswire (US) • 02/25/2026 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 09:11:26 PM
- Illumina launches TruPath Genome, setting a new standard in genomic insight • PR Newswire (US) • 02/24/2026 05:15:00 PM
- Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility • PR Newswire (US) • 02/23/2026 02:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2026 09:28:03 PM
